RYTM – rhythm pharmaceuticals, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

RYTM

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/12

01:13 pm

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

12/12

12:55 pm

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

12/12

12:55 pm

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

12/12

12:55 pm

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

12/12

06:03 am

rytm

Rhythm Pharmaceuticals (NASDAQ:RYTM) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..

Medium Report

Rhythm Pharmaceuticals (NASDAQ:RYTM) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..

Report

12/11

04:02 pm

rytm

Rhythm Pharmaceuticals (NASDAQ:RYTM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Medium Report

Rhythm Pharmaceuticals (NASDAQ:RYTM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Report

12/11

04:02 pm

rytm

Rhythm Pharmaceuticals (NASDAQ:RYTM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Medium Report

Rhythm Pharmaceuticals (NASDAQ:RYTM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Report

12/11

01:42 pm

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

12/11

01:42 pm

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

11/27

06:19 am

rytm

Rhythm Pharmaceuticals (NASDAQ:RYTM) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.

Low Report

Rhythm Pharmaceuticals (NASDAQ:RYTM) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.

Report

11/25

09:15 am

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

11/25

09:15 am

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

11/25

07:19 am

rytm

Rhythm Pharmaceuticals (NASDAQ:RYTM) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.

Low Report

Rhythm Pharmaceuticals (NASDAQ:RYTM) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.

Report

11/25

06:04 am

rytm

Rhythm Pharmaceuticals initiated with a Buy at Citi

Low Report

Rhythm Pharmaceuticals initiated with a Buy at Citi

Report

11/10

03:35 pm

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

11/7

02:41 pm

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

11/7

02:41 pm

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

11/5

05:01 am

rytm

Rhythm Pharmaceuticals (NASDAQ:RYTM) was downgraded by analysts at Oppenheimer Holdings, Inc. from an "outperform" rating to a "market perform" rating.

Medium Report

Rhythm Pharmaceuticals (NASDAQ:RYTM) was downgraded by analysts at Oppenheimer Holdings, Inc. from an "outperform" rating to a "market perform" rating.

Report

11/5

04:59 am

rytm

Rhythm Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer

Medium Report

Rhythm Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer

Report

11/5

04:59 am

rytm

Rhythm Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer

Medium Report

Rhythm Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer

Report

11/4

12:05 pm

rytm

Rating for RYTM

Medium Report

Rating for RYTM

Report

11/4

12:05 pm

rytm

Rating for RYTM

Medium Report

Rating for RYTM

Report

10/17

01:19 pm

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

10/17

01:19 pm

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

10/17

01:19 pm

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.